Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Advanced Breast Cancer (Female)
Interventions: DRUG: Palbociclib|DRUG: Letrozole
Sponsor: Pfizer